Charles L. Lucore

1.6k total citations
28 papers, 1.3k citations indexed

About

Charles L. Lucore is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Cancer Research. According to data from OpenAlex, Charles L. Lucore has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 11 papers in Hematology and 10 papers in Cancer Research. Recurrent topics in Charles L. Lucore's work include Protease and Inhibitor Mechanisms (10 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Acute Myocardial Infarction Research (6 papers). Charles L. Lucore is often cited by papers focused on Protease and Inhibitor Mechanisms (10 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Acute Myocardial Infarction Research (6 papers). Charles L. Lucore collaborates with scholars based in United States. Charles L. Lucore's co-authors include Burton E. Sobel, Janet B. McGill, Cynthia L. Arfken, David J. Schneider, Satoshi Fujii, Joseph J. Billadello, Frank V. Aguirre, Gregorio A. Sicard, Jeffrey M. Reilly and Krishna J. Rocha‐Singh and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Charles L. Lucore

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles L. Lucore United States	15	465	375	330	268	263	28	1.3k
Robert B. Francis United States	20	149 0.3×	244 0.7×	115 0.3×	203 0.8×	778 3.0×	38	1.5k
L. Heilmann Germany	21	437 0.9×	298 0.8×	60 0.2×	225 0.8×	422 1.6×	97	1.5k
Giuseppe Cella Italy	21	399 0.9×	294 0.8×	48 0.1×	428 1.6×	533 2.0×	87	1.4k
Hoyu Takahashi Japan	26	239 0.5×	380 1.0×	61 0.2×	226 0.8×	962 3.7×	84	1.6k
M. Blombäck Sweden	18	185 0.4×	176 0.5×	105 0.3×	133 0.5×	552 2.1×	46	1.0k
Mehmet Ertürk Türkiye	21	820 1.8×	205 0.5×	89 0.3×	340 1.3×	37 0.1×	172	1.5k
Thomas Maca Austria	18	316 0.7×	607 1.6×	89 0.3×	858 3.2×	41 0.2×	30	1.5k
Margareta Sten-Linder Sweden	15	583 1.3×	89 0.2×	94 0.3×	157 0.6×	476 1.8×	31	1.1k
José Mateo Spain	26	654 1.4×	290 0.8×	103 0.3×	343 1.3×	1.5k 5.8×	100	2.5k
Elena M. Faioni Italy	22	537 1.2×	219 0.6×	95 0.3×	269 1.0×	1.7k 6.3×	66	2.3k

Countries citing papers authored by Charles L. Lucore

Since Specialization

Citations

This map shows the geographic impact of Charles L. Lucore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles L. Lucore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles L. Lucore more than expected).

Fields of papers citing papers by Charles L. Lucore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles L. Lucore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles L. Lucore. The network helps show where Charles L. Lucore may publish in the future.

Co-authorship network of co-authors of Charles L. Lucore

This figure shows the co-authorship network connecting the top 25 collaborators of Charles L. Lucore. A scholar is included among the top collaborators of Charles L. Lucore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles L. Lucore. Charles L. Lucore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nguyen, James, Simcha Pollack, Stefan M. Muehlbauer, et al.. (2021). Electrocardiographic manifestations of COVID-19: Effect on cardiac activation and repolarization. EClinicalMedicine. 39. 101057–101057. 14 indexed citations

Jeremias, Allen, et al.. (2020). Prevalence of SARS-CoV-2 Infection Among Health Care Workers in a Tertiary Community Hospital. JAMA Internal Medicine. 180(12). 1707–1707. 46 indexed citations

Kolluri, Raghu, et al.. (2015). A randomized study of the safety and efficacy of fondaparinux versus placebo in the prevention of venous thromboembolism after coronary artery bypass graft surgery. American Heart Journal. 171(1). 1–6. 5 indexed citations

Aguirre, Frank V., Michael P. Kelley, Wilfred Lam, et al.. (2008). Rural Interhospital Transfer of ST-Elevation Myocardial Infarction Patients for Percutaneous Coronary Revascularization. Circulation. 117(9). 1145–1152. 93 indexed citations

Lucore, Charles L., Gregory Mishkel, Krishna J. Rocha‐Singh, et al.. (2001). Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospital. Coronary Artery Disease. 12(2). 135–142. 3 indexed citations

O’Rourke, Robert A., et al.. (2001). New Approaches to Diagnosis and Management of Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction. Archives of Internal Medicine. 161(5). 674–674. 7 indexed citations

Desai, Milind Y. & Charles L. Lucore. (2000). Uneventful use of tirofiban as an adjunct to coronary stenting in a patient with a history of abciximab-associated thrombocytopenia 10 months earlier.. PubMed. 12(2). 109–12. 11 indexed citations

Mishkel, Gregory, Frank V. Aguirre, Robert W. Ligon, Krishna J. Rocha‐Singh, & Charles L. Lucore. (1999). Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. Journal of the American College of Cardiology. 34(7). 1884–1890. 101 indexed citations

Lucore, Charles L., Gregory Mishkel, Robert W. Ligon, & Krishna J. Rocha‐Singh. (1999). Economic implications of coronary stenting with adjunctive IIb/IIIa receptor antagonists in a community hospital.. PubMed. 11 Suppl C. 14C–20C. 2 indexed citations

10.

Ligon, Robert W., Frank L. Mikell, James Dove, & Charles L. Lucore. (1998). Relationship of clinical variables to hospital cost for coronary interventions: a univariate and multivariate analysis. Journal of the American College of Cardiology. 31. 173–173. 1 indexed citations

11.

Rocha‐Singh, Krishna J., et al.. (1997). One balloon, one stent: An effective cost-containment strategy for elective stent deployment. Catheterization and Cardiovascular Diagnosis. 40(1). 17–20. 3 indexed citations

12.

Reilly, Jeffrey M., Gregorio A. Sicard, & Charles L. Lucore. (1994). Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. Journal of Vascular Surgery. 19(5). 865–872. 75 indexed citations

13.

Deitcher, Steven R., et al.. (1994). Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response. The American Journal of Medicine. 96(5). 483–484. 4 indexed citations

14.

Lucore, Charles L., et al.. (1992). Quantification of free tissue-type plasminogen activator in plasma from patients undergoing coronary thrombolysis. Coronary Artery Disease. 3(9). 831–838. 2 indexed citations

15.

Eisenberg, Richard, et al.. (1990). Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.. Circulation. 82(3). 841–847. 98 indexed citations

16.

Fujii, Satoshi, Charles L. Lucore, William E. Hopkins, Joseph J. Billadello, & Burton E. Sobel. (1989). Potential attenuation of fibrinolysis by growth factors released from platelets and their pharmacologic implications. The American Journal of Cardiology. 63(20). 1505–1511. 37 indexed citations

17.

Lucore, Charles L. & Burton E. Sobel. (1988). Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications.. Circulation. 77(3). 660–669. 118 indexed citations

18.

Lucore, Charles L., et al.. (1988). Biochemical determinants of clearance of tissue-type plasminogen activator from the circulation.. Circulation. 77(4). 906–914. 40 indexed citations

19.

Lucore, Charles L., Satoshi Fujii, Tze-Chein Wun, Burton E. Sobel, & Joseph J. Billadello. (1988). Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor.. Journal of Biological Chemistry. 263(31). 15845–15848. 85 indexed citations

20.

McDonald, Malcolm, Charles L. Lucore, & David T. Durack. (1984). An experimental model for pyogenic liver abscess. Journal of Infection. 8(2). 129–136. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact